Skip to main content

Immunotherapy

Meeting Highlights

Nivolumab Monotherapy as Bridge to Transplant in Patients with Relapsed or Refractory Hodgkin Lymphoma

FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer

CAR T-Cell Therapy Targeting Solid Tumors

Meeting Highlights

Checkpoint Inhibitor a New Approach to Jump-Start a Waning Response to CAR T-Cell Therapy

Phoebe Starr, Medical Writer

Explosive Development of BCMA CAR T-Cell Therapy for Multiple Myeloma

Avelumab plus Axitinib Combination Improves Outcomes in Advanced Renal-Cell Carcinoma

Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer

Building on the Successes of Cancer Immunotherapy

Nivolumab plus Ipilimumab Combo Controls Brain Metastases in Patients with Skin Cancer

CAR T-Cell Therapy Yields Impressive Responses in Aggressive Blood Cancer

1
2
3
4

Page 3 of 4
Results 21 - 30 of 35